177 related articles for article (PubMed ID: 30192897)
1. A situational analysis of latent tuberculosis infection among incarcerated population in Japan.
Kawatsu L; Uchimura K; Ohkado A
PLoS One; 2018; 13(9):e0203815. PubMed ID: 30192897
[TBL] [Abstract][Full Text] [Related]
2. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
Kawatsu L; Uchimura K; Ohkado A
BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
[TBL] [Abstract][Full Text] [Related]
3. Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.
Kawatsu L; Uchimura K; Ohkado A
PLoS One; 2017; 12(11):e0186588. PubMed ID: 29091917
[TBL] [Abstract][Full Text] [Related]
4. Completion Rates, Adverse Effects, and Costs of a 3-Month and 9-Month Treatment Regimen for Latent Tuberculosis Infection in California Inmates, 2011-2014.
Wheeler C; Mohle-Boetani J
Public Health Rep; 2019; 134(1_suppl):71S-79S. PubMed ID: 31059418
[TBL] [Abstract][Full Text] [Related]
5. [A SYSTEMATIC REVIEW ON THE PREVALENCE AND INCIDENCE OF LATENT TUBERCULOSIS INFECTION AMONG PRISON POPULATION].
Kawatsu L; Uchimura K; Izumi K; Ohkado A
Kekkaku; 2016 Apr; 91(4):457-64. PubMed ID: 27530018
[TBL] [Abstract][Full Text] [Related]
6. Active and latent tuberculosis in Brazilian correctional facilities: a cross-sectional study.
Carbone Ada S; Paião DS; Sgarbi RV; Lemos EF; Cazanti RF; Ota MM; Junior AL; Bampi JV; Elias VP; Simionatto S; Motta-Castro AR; Pompílio MA; de Oliveira SM; Ko AI; Andrews JR; Croda J
BMC Infect Dis; 2015 Jan; 15():24. PubMed ID: 25608746
[TBL] [Abstract][Full Text] [Related]
7. Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.
Nijhawan AE; Iroh PA; Brown LS; Winetsky D; Porsa E
BMC Infect Dis; 2016 Oct; 16(1):564. PubMed ID: 27733123
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
[TBL] [Abstract][Full Text] [Related]
9. Treatment of latent tuberculosis infection in incarcerated people: a systematic review.
Matucci T; Riccardi N; Occhineri S; Pontarelli A; Tiseo G; Falcone M; Puci M; Saderi L; Sotgiu G
Clin Microbiol Infect; 2023 Jun; 29(6):714-721. PubMed ID: 36868354
[TBL] [Abstract][Full Text] [Related]
10. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
Schein YL; Madebo T; Andersen HE; Arnesen TM; Dyrhol-Riise AM; Tveiten H; White RA; Winje BA
BMC Infect Dis; 2018 Nov; 18(1):587. PubMed ID: 30453946
[TBL] [Abstract][Full Text] [Related]
11. Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation.
Spruijt I; Erkens C; Suurmond J; Huisman E; Koenders M; Kouw P; Toumanian S; Cobelens F; van den Hof S
PLoS One; 2019; 14(7):e0219252. PubMed ID: 31260502
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of latent tuberculosis infection and associated risk factors in prison in East Wollega Zone of western Ethiopia.
Chekesa B; Gumi B; Chanyalew M; Zewude A; Ameni G
PLoS One; 2020; 15(5):e0233314. PubMed ID: 32428042
[TBL] [Abstract][Full Text] [Related]
13. Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting.
Dale KD; Abayawardana MJ; McBryde ES; Trauer JM; Carvalho N
Am J Epidemiol; 2022 Jan; 191(2):255-270. PubMed ID: 34017976
[TBL] [Abstract][Full Text] [Related]
14. IGRA-Based Screening for Latent Tuberculosis Infection in Persons Newly Incarcerated in New York City Jails.
Katyal M; Leibowitz R; Venters H
J Correct Health Care; 2018 Apr; 24(2):156-170. PubMed ID: 29633660
[TBL] [Abstract][Full Text] [Related]
15. Practices and attitudes towards tuberculosis and latent tuberculosis infection screening in people living with HIV/AIDS among HIV physicians in Japan.
Kawatsu L; Kaneko N; Imahashi M; Kamada K; Uchimura K
AIDS Res Ther; 2022 Dec; 19(1):60. PubMed ID: 36463211
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness study of tuberculosis and latent tuberculosis infection screening in prisons in Japan.
Kawatsu L; Uchimura K; Ohkado A
Int J Tuberc Lung Dis; 2020 May; 24(5):506-511. PubMed ID: 32398200
[No Abstract] [Full Text] [Related]
17. Treatment guidelines for latent tuberculosis infection.
;
Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
[TBL] [Abstract][Full Text] [Related]
18. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
Haukaas FS; Arnesen TM; Winje BA; Aas E
Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
[TBL] [Abstract][Full Text] [Related]
19. Cross-sectional study of prevalence and risk factors, and a cost-effectiveness evaluation of screening and preventive treatment strategies for latent tuberculosis among migrants in Singapore.
Lim VW; Wee HL; Lee P; Lin Y; Tan YR; Tan MX; Lin LW; Yap P; Chee CB; Barkham T; Lee V; Chen M; Ong RT
BMJ Open; 2021 Jul; 11(7):e050629. PubMed ID: 34266845
[TBL] [Abstract][Full Text] [Related]
20. High Completion Rate for 12 Weekly Doses of Isoniazid and Rifapentine as Treatment for Latent Mycobacterium tuberculosis Infection in the Federal Bureau of Prisons.
Schmit KM; Lobato MN; Lang SG; Wheeler S; Kendig NE; Bur S
J Public Health Manag Pract; 2019; 25(2):E1-E6. PubMed ID: 30024493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
